Ignite Creation Date:
2024-05-06 @ 10:31 AM
Last Modification Date:
2024-10-26 @ 12:31 PM
Study NCT ID:
NCT03282643
Status:
COMPLETED
Last Update Posted:
2019-04-16
First Post:
2017-09-12
Brief Title:
Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients
Sponsor:
Capital Medical University
Organization:
Capital Medical University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-16
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-01
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-12
First Submit QC Date:
September 13 2017
Study First Post Date:
2017-09-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-15
Last Update Post Date:
2019-04-16
Last Update Post Date Type:
ACTUAL